DYSPAREUNIA: CMS CLARIFICATION RESULTS IN EXPANDED TREATMENT AND COVERAGE UNDER MEDICARE PART D

ISSWSH is pleased to announce and recognize the Centers for Medicare and Medicaid Services (CMS) clarification of the statutory intent of “Prescription Drug Benefits” section 1860D-2(e)(2)(A) of the Social Security Act, stating that drugs for the treatment of moderate to severe dyspareunia (pain during sexual intercourse) due to menopause, are not excluded from Medicare Part D coverage when used consistent with this labeling.

 

ISSWSH, alongside the North American Menopause Society (NAMS), the American College of Obstetricians and Gynecologists (ACOG), and many other interested parties are committed to women’s health and particularly sexual health. James A. Simon, MD, President of ISSWSH, thanks these partners and commends CMS for this clarification that now allows women suffering from dyspareunia, to access expanded treatment options and get coverage under Medicare Part D.

View Press Release

Save the Date

ISSWSH Sexual Pain Course 2020
April 17-18, 2020
CANCELLED DUE TO COVID-19
Read more...

ISSWSH Fall Course 2020
November 19-21, 2020   235 days left
DoubleTree Hilton Hotel, Scottsdale, AZ - USA
Read more...

ISSWSH Annual Meeting 2021
March 4-7, 2021   340 days left
Renaissance Dallas Hotel, Dallas, TX, USA

Latest Tweets

“No research can be truly meaningful if there is not a regulatory agency that will allow developers to put forward… https://t.co/lGlT88qH4U ISSWSH
Time to Orgasm in Women in a Monogamous Stable Heterosexual Relationship was 13 minutes in this study. https://t.co/3ovAvTUcRa ISSWSH
Endometriosis apps include symptom trackers, education, & support for women w/this condition. Do apps have a role i… https://t.co/4T9KMOVJm3 ISSWSH

Contact Details

ISSWSH Executive Office
14305 Southcross Dr
Suite 100
Burnsville, MN 55306
USA

Phone: +1 (952) 683 9025
Fax: +1 (952) 314 8212
Email: This email address is being protected from spambots. You need JavaScript enabled to view it.

Follow us on Twitter!